심장 이식형 전자기기 시장 : 종류별, 최종사용자별, 지역별

Cardiac Implantable Electronic Device Market is estimated to be valued at USD 35.26 Bn in 2026 and is expected to reach USD 60.43 Bn by 2033, growing at a compound annual growth rate (CAGR) of 8.0% from 2026 to 2033.

Cardiac implants are devices that are implanted in the heart tissue, in order to control irregular heart function. Cardiac implants such as pacemakers, defibrillator implants, and cardiac rhythm monitoring implants are available in the market to treat cardiac dysfunction such as heart rhythm disorders, arrhythmias, and other heart related disorders. These cardiac implants are majorly prescribed to patients with heart failure. Cardiac implants have been developed with innovative technical features in the recent years, and this has improved quality of life of patients with heart failure. A pacemaker insertion is the implantation of a small electronic device that is usually placed in the chest (just below the collarbone) to regulate slow electrical problems related to heart. A pacemaker can be recommended to ensure that the heartbeat does not slow to a dangerously low rate. There are three kind of pacemakers: single chamber- one lead attaches to the upper or lower heart chamber, dual-chamber- it uses two leads, one for the upper and one for the lower chamber, and biventricular pacemakers that is used in cardiac resynchronization therapy. An implantable cardioverter-defibrillator (ICD) is a small battery-powered device that is placed in the chest to detect, and to stop irregular heartbeats (arrhythmias). An ICD continuously monitors the heartbeat and delivers electric shocks, when needed, to restore a regular heart rhythm. Increasing incidence of cardiac arrhythmia, aging population, and demographic changes are expected to drive the global cardiac implantable electronic device market growth over the forecast period.

Market Dynamics

Increasing prevalence of cardiovascular diseases such as cardiac arrhythmia, coronary artery disease, and others, aging population, and demographic changes are expected to drive the global cardiac implantable electronic device market growth over the forecast period. For instance, on May 15, 2023, according to the Centers for Disease Control and Prevention, in the U.S., heart disease caused around 695,000 deaths in 2021, accounting for 1 in every 5 fatalities and around 1 in 20 adults aged 20 and older have coronary artery disease (CAD).

Key features of the study:

• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global cardiac implantable electronic device market based on the following parameters- company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study are Medtronic, Biotronik, Boston Scientific Corporation or its affiliates, Pacetronix.com, Integer Holdings Corporation, Cook Group, Braile Biomedica, Abbott, LivaNova PLC, OSYPKA Medical, Galix Biomedical Instrumentation Inc., OSCOR Inc., LifeTech Scientific Corporation, MicroPort Scientific Corporation, and Ceryx Medical
• Insights from this report will allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global cardiac implantable electronic device market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cardiac implantable electronic device market

Detailed Segmentation:

• Global Cardiac Implantable Electronic Device Market, By Type (Revenue, USD Bn, 2021 - 2033)
• Implantable Pacemakers
• External Pacemakers
• Global Cardiac Implantable Electronic Device Market By End User:
• Hospitals
• Specialty Clinics
• Ambulatory Care Settings
• Global Cardiac Implantable Electronic Device Market, By Region (Revenue, USD Bn, 2021 - 2033)
• North America
  • U.S.
  • Canada
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
• Middle East
  • GCC
  • Israel
  • Rest of Middle East
• Africa
  • South Africa
  • Central Africa
  • North Africa
• Company Profiles
• Medtronic
• Biotronik
• Boston Scientific Corporation or its affiliates
• Pacetronix.com
• Integer Holdings Corporation
• Cook Group
• Braile Biomedica
• Abbott
• LivaNova PLC
• OSYPKA Medical
• Galix Biomedical Instrumentation Inc.
• OSCOR Inc.
• LifeTech Scientific Corporation
• MicroPort Scientific Corporation
• Ceryx Medical

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Type
  • Market Snapshot, By End User
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Attractiveness Analysis
  • Market Opportunities
  • Merger, Acquisition, and Collaborations
  • Funding and Investment
  • Regulatory Guideline and Compliances
  • Key Developments
  • PEST Analysis
  • PORTER's Analysis

4. Global Cardiac Implantable Electronic Device Market, By Type, 2021 - 2033, (US$ Billion)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022-2033
  • Segment Trends
• Implantable Pacemakers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
• External Pacemakers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)

5. Global Cardiac Implantable Electronic Device Market, By End User, 2021 - 2033, (US$ Billion)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022-2033
  • Segments Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
• Specialty Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
• Ambulatory Care Settings
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)

6. Global Cardiac Implantable Electronic Device Market, By Region, 2021 - 2033, (US$ Billion)

• Introduction
  • Market Share Analysis, By Region, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, For Region, 2022-2033
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Billion)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Billion)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Billion)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Billion)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Billion)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (US$ Billion)
    • North Africa
    • Central Africa
    • South Africa

7. Competitive Landscape

• Medtronic
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Biotronik
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Boston Scientific Corporation or its affiliates
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Pacetronix.com
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Integer Holdings Corporation
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Cook Group
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Braile Biomedica
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Abbott
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• LivaNova PLC
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• OSYPKA Medical
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Galix Biomedical Instrumentation Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• OSCOR Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• LifeTech Scientific Corporation
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• MicroPort Scientific Corporation
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Ceryx Medical
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies

8. Section

• Research Methodology
• About Us